ADVI Health’s Tyler Seville Featured in Pharmaceutical Executive to Discuss 340B
Recently, ADVI Health’s associate director, market access policy strategy (MAPS), Tyler Seville, was featured in Pharmaceutical Executive to discuss the status of the 340B program, rising policy concerns regarding 340B, how 340B works alongside the Inflation Reduction Act (IRA), and more.
Read more in Pharmaceutical Executive:
- The Current Status of the 340B Program
- Modern Policy Concerns Stemming from 340B
- The Impact from Overlaps Between 340B and the IRA
- Why 340B Reform is Overdue: Q&A with Tyler Seville
Get in touch with the ADVI Health team for more insights
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.